Hologic (FRA:HO1) ROE % Adjusted to Book Value: 4.51% (As of Dec. 2025)

Hologic FRA:HO1 57 ROE % Adjusted to Book Value is 4.51% as of Dec. 2025. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 5 warning signs investors should review.

Hologic's ROE % for the quarter that ended in Dec. 2025 was 13.94%. Hologic's PB Ratio for the quarter that ended in Dec. 2025 was 3.09. Hologic's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 4.51%.

Hologic ROE % Adjusted to Book Value Related Terms

Hologic ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Hologic's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic ROE % Adjusted to Book Value Chart

Hologic Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

11.89

9.28

2.64

4.23

3.66

Hologic Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															4.91	-0.49	5.43	5.09	4.51

FRA:HO1 vs WST, COO, ALGN: ROE % Adjusted to Book Value Comparison

For the Medical Instruments & Supplies subindustry, Hologic's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hologic ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hologic's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hologic's ROE % Adjusted to Book Value falls into.

Save Embed

57GF Score

Hologic Inc FRA:HO1

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Hologic ROE % Adjusted to Book Value Calculation

Hologic's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.80%	/	2.95
	=	3.66%

Hologic's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.94%	/	3.09
	=	4.51%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 4.51% mean?

Hologic (FRA:HO1) has a ROE % Adjusted to Book Value of 4.51% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Hologic and its competitors.

Is Hologic's ROE % Adjusted to Book Value too high?

Hologic's current ROE % Adjusted to Book Value is 4.51%. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.

How does Hologic's ROE % Adjusted to Book Value compare to WST and COO?

Hologic's ROE % Adjusted to Book Value of 4.51% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?

A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Hologic and its competitors. Hologic's current ROE % Adjusted to Book Value is 4.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Hologic stock overvalued right now?

Hologic (FRA:HO1) has a current ROE % Adjusted to Book Value of 4.51%. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current ROE % Adjusted to Book Value is 4.51%. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Hologic (FRA:HO1), the current ROE % Adjusted to Book Value is 4.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hologic (FRA:HO1) Overvalued in 2026?

Based on GuruFocus' analysis, Hologic stock appears to be undervalued. The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.

Key valuation signals for FRA:HO1:

ROE % Adjusted to Book Value: 4.51%
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hologic Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies WST COO ALGN SOLV BAX ATR RGEN TFX AVTR MMSI ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD TSE:4543 XPAR:DIM XSWX:STMN

Address 250 Campus Drive, Marlborough, MA, USA, 01752

Website https://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

57GF Score

Get the complete analysis for FRA:HO1

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00

Price

€70.17

GF Value

View FRA:HO1 Analysis

See ROE % Adjusted to Book Value data for all stocks →